In this whitepaper, our experts delve into challenges of antibody-drug conjugate (ADC) production, in particular the complex logistics and multifaceted manufacturing. Logistics are vital for ADCs due the production of multiple components including the monoclonal antibody (biologic), a linker (small molecule) and a potent warhead (typically cytotoxic). Each component requires multiple partners handling manufacturing stages. The paper discusses how Eurofins CDMO Alphora (Eurofins Alphora) provides an integrated solution to streamline operations for manufacturing under one roof.
Please check the highlighted fields and try again.
Please fill out the information below. If you are already registered, login and this information will be filled out for you.
Please enter your first and last name.
Please enter the name of the company or institution you work at.
Please enter your mailing address.
Please enter the phone number you would like to be contacted at.
Please enter the e-mail address you would like to be contacted at.
Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.